Summary
Updated Aug 30, 2026
Amit Munshi files SEC Form 4 reports at Inhibikase Therapeutics, Inc. (IKT). 8 SEC Form 4 filings on record going back to 2024, most recently on 30 June 2026. Most recent open-market trade: bought $500K of IKT on 23 October 2024. Lifetime open-market purchases: $500K.
Recent Transactions
4Every recent SEC Form 4 transaction Amit Munshi has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Amit Munshi files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- AI Biotechnology LLC - $12.50M of ZURA open-market activity in the last 12 months
- Todd Watanabe - $5.50M of ARQT open-market activity in the last 12 months
- Sands Capital Life Sciences Pulse Fund II, L.P. - $3.00M of IKT open-market activity in the last 12 months
- Masaru Matsuda - $2.45M of ARQT open-market activity in the last 12 months
- Howard G. Welgus - $2.18M of ARQT open-market activity in the last 12 months
- Patrick Burnett - $1.56M of ARQT open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Amit Munshi?
Amit Munshi is a corporate insider of Inhibikase Therapeutics, Inc. (IKT). InsiderAlpha holds 8 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Amit Munshi submitted recently?
3 primary Form 4 filings in the last 90 days, covering 3 companies.
Has Amit Munshi been buying or selling stock?
Recorded transactions: 1 open-market purchase ($500K) and 0 open-market sales across all tracked filings.
Where can I see all of Amit Munshi's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Amit Munshi and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
